{"id":"bifilact","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Mild abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bifilact contains live Bifidobacterium longum bacteria that colonize the intestinal tract, promoting a healthy microbiome balance. By restoring commensal bacteria, it may reduce pathogenic overgrowth, improve intestinal barrier function, and modulate local and systemic immune responses. This mechanism is intended to address dysbiosis-related conditions and support gastrointestinal health.","oneSentence":"Bifilact is a probiotic therapeutic that restores beneficial bacterial flora to treat or prevent gastrointestinal and related disorders.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:43:21.214Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Restoration of normal intestinal microbiota in dysbiosis"},{"name":"Gastrointestinal disorders associated with bacterial imbalance"}]},"trialDetails":[{"nctId":"NCT01839721","phase":"PHASE3","title":"Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2006-12","conditions":"Cancer, Diarrhea, Abdominal Pain","enrollment":246}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["probiotics"],"phase":"phase_3","status":"active","brandName":"Bifilact®","genericName":"Bifilact®","companyName":"CHU de Quebec-Universite Laval","companyId":"chu-de-quebec-universite-laval","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bifilact is a probiotic therapeutic that restores beneficial bacterial flora to treat or prevent gastrointestinal and related disorders. Used for Restoration of normal intestinal microbiota in dysbiosis, Gastrointestinal disorders associated with bacterial imbalance.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}